122 related articles for article (PubMed ID: 7142023)
1. Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
Sugimoto Y; Suzuki H; Yamaki H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1982 Sep; 35(9):1222-30. PubMed ID: 7142023
[TBL] [Abstract][Full Text] [Related]
2. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
3. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
5. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.
Kunimoto S; Miura K; Takahashi Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Mar; 36(3):312-7. PubMed ID: 6833151
[TBL] [Abstract][Full Text] [Related]
6. Studies on antineoplastic activity of naphthomycin, a naphthalenic ansamycin, and its mode of action.
Okabe T; Yuan BD; Isono F; Sato I; Fukazawa H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1985 Feb; 38(2):230-5. PubMed ID: 3997667
[TBL] [Abstract][Full Text] [Related]
7. Arene cis-dihydrodiols: useful precursors for the preparation of analogues of the anti-tumour agent, 2-crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone (COTC).
Arthurs CL; Raftery J; Whitby HL; Whitehead RC; Wind NS; Stratford IJ
Bioorg Med Chem Lett; 2007 Nov; 17(21):5974-7. PubMed ID: 17870533
[TBL] [Abstract][Full Text] [Related]
8. Analogues of 2-crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone (COTC) with anti-tumor properties.
Arthurs CL; Wind NS; Whitehead RC; Stratford IJ
Bioorg Med Chem Lett; 2007 Jan; 17(2):553-7. PubMed ID: 17174551
[TBL] [Abstract][Full Text] [Related]
9. Uptake and binding of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and 3'-(4-morpholinyl)-3'-deaminoadriamycin in L5178Y lymphoblasts in vitro.
Begleiter A; Jesson MI; Johnston JB
Cancer Commun; 1990; 2(1):7-12. PubMed ID: 2196074
[TBL] [Abstract][Full Text] [Related]
10. Arabinosyl nucleosides. XXXII. Mechanism of inhibition of L5178y mouse lymphoma cells by 9-beta-D-arabinofuranosylguanine.
Müller WE; Geurtsen W; Beyer R; Schuster DK; Zahn RK; Arendes J
Chem Biol Interact; 1981 Mar; 34(3):301-13. PubMed ID: 7460088
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA synthesis in murine tumor cells by geldanamycin, an antibiotic of the benzoquinoid ansamycin group.
Yamaki H; Suzuki H; Choi EC; Tanaka N
J Antibiot (Tokyo); 1982 Jul; 35(7):886-92. PubMed ID: 6897401
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of shikimate analogues. Structure:activity studies based on 1-crotonyloxymethyl-3R,4R,5R-trihydroxycyclohex-2-enone.
Aghil O; Bibby MC; Carrington SJ; Double J; Douglas KT; Phillips RM; Shing TK
Anticancer Drug Des; 1992 Feb; 7(1):67-82. PubMed ID: 1543528
[TBL] [Abstract][Full Text] [Related]
13. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
Johnson RK; Chitnis MP; Embrey WM; Gregory EB
Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
[TBL] [Abstract][Full Text] [Related]
14. DNA strand scission in vivo and in vitro by auromomycin.
Suzuki H; Nishimura T; Tanaka N
Cancer Res; 1979 Jul; 39(7 Pt 1):2787-91. PubMed ID: 445483
[TBL] [Abstract][Full Text] [Related]
15. Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.
Suzuki H; Sugimoto Y; Tanaka K; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1984 May; 37(5):602-9. PubMed ID: 6547433
[TBL] [Abstract][Full Text] [Related]
16. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro.
Begleiter A; Leith MK; Johnston JB
Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485
[TBL] [Abstract][Full Text] [Related]
17. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Biochem Pharmacol; 1978; 27(17):2123-30. PubMed ID: 31880
[No Abstract] [Full Text] [Related]
18. Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.
Nishimura T; Suzuki H; Muto K; Tanaka N
J Antibiot (Tokyo); 1979 May; 32(5):518-22. PubMed ID: 583339
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
20. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
